CFHR3 Polyklonaler Antikörper

CFHR3 Polyklonal Antikörper für IHC, IP, WB, ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus, Ratte

Anwendung

WB, IP, IHC, IF, ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 16583-1-AP

Synonyme

CFHL3, CFHR3, complement factor H related 3, DOWN16, FHR 3, FHR3, H factor like protein 3, HLF4



Geprüfte Anwendungen

Erfolgreiche Detektion in WBMauslebergewebe, humanes Herzgewebe, Rattenlebergewebe
Erfolgreiche IPHepG2-Zellen
Erfolgreiche Detektion in IHChumanes Lebergewebe
Hinweis: Antigendemaskierung mit TE-Puffer pH 9,0 empfohlen. (*) Wahlweise kann die Antigendemaskierung auch mit Citratpuffer pH 6,0 erfolgen.

Empfohlene Verdünnung

AnwendungVerdünnung
Western Blot (WB)WB : 1:1000-1:4000
Immunpräzipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunhistochemie (IHC)IHC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Produktinformation

16583-1-AP bindet in WB, IP, IHC, IF, ELISA CFHR3 und zeigt Reaktivität mit human, Maus, Ratten

Getestete Reaktivität human, Maus, Ratte
In Publikationen genannte Reaktivitäthuman
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen CFHR3 fusion protein Ag9963
Vollständiger Name complement factor H-related 3
Berechnetes Molekulargewicht 330 aa, 37 kDa
Beobachtetes Molekulargewicht 45-56 kDa
GenBank-ZugangsnummerBC058009
Gene symbol CFHR3
Gene ID (NCBI) 10878
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3.
LagerungsbedingungenBei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

CFHR3, also named as DOWN16, belongs to the complement factor H-related protein family. Expressed by the liver and secreted in plasma, human CFHR3 is composed of five short consensus repeats (SCRs), and it also has a 19-amino acid signal peptide and four N-linked glycosylation sites. It may be involved in complement regulation. Deletion of CFHR1 and CFHR3 genes was found to be associated with decreased risk of age-related macular degeneration (AMD), and with an increased risk of atypical hemolytic-uremic syndrome (aHUS).

Protokolle

Produktspezifische Protokolle
WB protocol for CFHR3 antibody 16583-1-APProtokoll herunterladen
IHC protocol for CFHR3 antibody 16583-1-APProtokoll herunterladen
IP protocol for CFHR3 antibody 16583-1-APProtokoll herunterladen
Standard-Protokolle
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen

Publikationen

SpeciesApplicationTitle
humanWB

Clin Cancer Res

Complement regulatory proteins CFHR1 and CFHR3 and patient response to anti-CD20 monoclonal antibody therapy.

Authors - Laura M Rogers
humanWB

Sci Rep

A haplotype in CFH family genes confers high risk of rare glomerular nephropathies.

Authors - Yin Ding
humanIF

Exp Eye Res

Quantitative analysis of hydroxyapatite-binding plasma proteins in genotyped individuals with late-stage age-related macular degeneration.

Authors - Swati Arya
humanWB

PLoS One

A novel quantitative hemolytic assay coupled with restriction fragment length polymorphisms analysis enabled early diagnosis of atypical hemolytic uremic syndrome and identified unique predisposing mutations in Japan.

Authors - Yoko Yoshida
humanWB,IHC

Bioengineered

A novel hypoxia-driven gene signature that can predict the prognosis of hepatocellular carcinoma.

Authors - Zhirui Zeng
humanWB

Mol Med Rep

Complement factor H‑related 3 overexpression affects hepatocellular carcinoma proliferation and apoptosis.

Authors - Hong Liu